您的浏览器禁用了JavaScript(一种计算机语言,用以实现您与网页的交互),请解除该禁用,或者联系我们。 [港股财报]:创美药业2024中期报告 - 发现报告

创美药业2024中期报告

2024-09-27 港股财报 胡冠群
报告封面

創美藥業股份有限公司(「本公司」或「我們」,連同其附屬公司,統稱「本 集 團」 )( 股 份 代 號 :2289.HK)主營醫藥分銷業務,主要向下游分銷商和零售終端分銷西藥、中成藥、保健品等產品,同時也開展第三方物流服務,並提供醫藥產品諮詢服務。本公司創立於2000年,經過24年的快速發展,已成長為華南地區領先的醫藥分銷商之一。本公司堅持「深耕廣東,輻射周邊」的發展戰略,立足於汕頭,在廣州、珠海、惠州、佛山及深圳成立子公司,並擁有四個現代化醫藥物流中心,專業的營銷服務團隊以及運輸服務團隊,對非招標市場實行「半徑10公里內一日三配、50公里內一日兩配、250公里內一日一配」的高效配送機制。本公司具有現代化信息系統,涵蓋整個醫藥分銷供應鏈,包括採購、銷售、倉儲、運輸及交付等。本公司同時運營自建的B2B電子商務平臺:「創美e藥」,供客戶線上下單、查詢及支付等。本公司於2023年全國批發企業主營業務收入前100位排序35。本公司於廣東省醫藥流通企業排名第6位。 Charmacy Pharmaceutical Co., Ltd.(the “Company” or “we”,together with its subsidiaries, collectively, the “Group”)(stockcode: 2289.HK) is principally engaged in the pharmaceuticaldistribution business. It mainly distributes western medicine,Chinese patent medicine and healthcare products to downstreamdistributors and retail terminals,while conducting dealings in thethird-party logistics business of medicines and providingpharmaceutical products related consulting services. Founded in2000, over the past24years of rapid development, it has becomeone of the leading pharmaceutical distributors in the SouthernChina region. The Company adheres to the development strategyof “Intensive Engagement in Guangdong Province and ExtensiveCoverageacross Surrounding Areas”, based in Shantou, it hasestablished subsidiaries in Guangzhou, Zhuhai, Huizhou, Foshanand Shenzhen, and has four modern pharmaceutical logisticscenters., all equipped with Professional marketing service team,professional transportation teams, and has a highly efficientdelivery mechanism of delivering pharmaceutical products threetimes per day for customers within a radius of 10 kilometers,twice per day for customers within a radius of 50 kilometers andonce per day for those within a radius of 250 kilometers. Inaddition, the Company has a modern information system thatcovers the entire supply chain for pharmaceutical distribution,including procurement, sales, warehousing, transportation anddelivery. Apart from that, theCompany operates its own B2B e-commerce platform “Charmacy e-Medicine” (創美e藥), aplatform for customers to place orders online, make inquires andpayment,etc. In2023, the Company ranked top35among top100thePRC wholesalers, in respect of revenue generated fromthe principal business. The Company ranked the 6th among thepharmaceutical distribution businesses in Guangdong Province. In the first half of 2024,the Group was recognised as anExcellent Pharmaceutical Logistics and Distribution Enterprisein 2023–2024 by theYaolianquan Certification Centre (for 4consecutiveyears),a Modern Pharmaceutical LogisticsTechnology Test Base (Centre) in 2023–2024 (for 3 consecutiveyears), and the Best Pharmaceutical Cold Chain Logistics Centre(Base) in 2023–2024 (for 6 consecutive years), a RecommendedEnterprise for Pharmaceutical Cold Chain Logistics Services in2023–2024 (for 5 consecutive years), and awarded the ChinaLogistics Industry "Golden Ant" Innovation Award in 2023–2024bythe Organising Committee of China(Guangzhou)International Logistics Equipment and Technology Exhibition(for 7 consecutive years). 2024年上半年,本集團新獲得由藥鏈圈認證中心頒發的2023-2024年度醫藥物流配送優秀企業(連續4年獲得)、2023-2024年度現代醫藥物流技術試驗基地(中心)(連續3年獲得)、2023-2024年度醫藥冷鏈最佳物 流 中 心 ( 基 地 ) ( 連 續6年 獲得)、2023-2024年度醫藥冷鏈物流服務推薦企業(連續5年獲得),獲得由中國(廣州)國際物流裝備與技術展會組委會頒發的2023-2024年度中國物流行業金螞蟻創新獎(連續7年獲得)。 公司資料Corporate Information1 財務摘要Financial Summary 4 管理層討論及分析Management Discussion and Analysis5 其他資料Other Information 26 32 49 *董事 *DIRECTORS 執行董事 Executive Directors 姚創龍(董事會副主席)鄭玉燕張寒孜 Yao Chuanglong (Vice-chairman of the Board) Zheng YuyanZhang Hanzi 非執行董事 Non-executive Directors Yan Jingbin (Chairman of the Board) Fu Zheng Xu Fei 獨立非執行董事 Independent non-executive Directors 李漢國尹智偉關鍵(又稱關蘇哲) Li HanguoWan Chi Wai AnthonyGuan Jian (also known as Guan Suzhe) *SUPERVISORS *監事 朱明洪張玲鄭禧玥 Zhu MinghongZhang LingZheng Xiyue *聯席公司秘書 *JOINT COMPANY SECRETARIES 黃慧玲姚潔晞 *審核委員會 *AUDIT COMMITTEE Wan Chi Wai Anthony (Chairman) *提名委員會 *NOMINATION COMMITTEE 關鍵(主席)姚創龍李漢國 Guan Jian (Chairman)Yao ChuanglongLi Hanguo *薪酬委員會 *REMUNERATION COMMITTEE 李漢國(主席)付征尹智偉 Li Hanguo (Chairman)Fu ZhengWan Chi Wai Anthony *風險管理委員會 *RISK MANAGEMENT COMMITTEE 姚創龍(主席)張寒孜李漢國 Yao Chuanglong (Chairman)Zhang HanziLi Hanguo *戰略發展委員會 *STRATEGIC DEVELOPMENT COMMITTEE 嚴京斌(主席)姚創龍鄭玉燕 Yan Jingbin (Chairman)Yao ChuanglongZheng Yuyan *授權代表 * AUTHORISED REPRESENTATIVES 鄭玉燕姚潔晞 Yao Jiexi *核數師 * AUDITOR 信永中和會計師事務所(特殊普通合夥) ShineWingCertified Public Accountants(Special GeneralPartnership) *法律顧問 * LEGAL ADVISERS DeHeng Law Offices (Hong Kong) LLP (as to Hong Kong laws) 德恒律師事務所(香港)有限法律責任合夥(香港法律) 廣東信達律師事務所(中國法律) Sundial Law Firm (as to the PRC laws) *註冊辦公室及總部 * REGISTERED OFFICE AND HEADQUARTERS 中國廣東省汕頭市龍湖區嵩山北路235號 No. 235, Song Shan North Road, Longhu District, Shantou City,Guangdong Province, the PRC -002- *香港主要營業地點 *PRINCIPAL PLACE OF BUSINESS IN HONG KONG 香港灣仔皇后大道東248號大新金融中心40樓 40th Floor, Dah Sing Financial Centre, No. 248 Queen’s RoadEast,Wanchai, Hong Kong *主要往來銀行 * PRINCIPAL BANKS 廣發銀行股份有限公